Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECISION BIOSCIENCES INCDTIL · Entity 6284 | Director | September 25, 2026 | September 29, 2026 |
| TAPESTRY, INC.TPR · Entity 2309 | SVP, Controller and PAO | August 17, 2018 | August 20, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECISION BIOSCIENCES INC
Report date September 25, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,481 |
Reported balance
After 2026-09-25 transaction · row 1
1 source rowRow 1 · 2026-09-25 · Purchase · Acquired 1,135 · Balance 45,481 |
TAPESTRY, INC.
Report date August 17, 2018 · Filed August 20, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,155 |
Reported balance
After 2018-08-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-08-17 · Tax withholding · Disposed 780 · Balance 32,155 F1: These shares were withheld to pay for the taxes in connection with the vesting of the restricted stock units on the Transaction Date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld to pay for the taxes in connection with the vesting of the restricted stock units on the Transaction Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 29, 2026 11:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 1,135 | $6.27 | $7,116.45 |
DisclosureSEC source: 0001628280-26-063767 · wk-form4_1790679617.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,481 Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 11:39 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 20,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041045 · wk-form4_1780659547.xml · derivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,979 Underlying: Common Stock · 20,979 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 11:30 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037536 · wk-form4_1779449447.xml · derivative · entry 2 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 11:30 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 21,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-037536 · wk-form4_1779449447.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 12:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 1,381 | $4.97 | $6,863.57 |
DisclosureSEC source: 0001628280-25-057482 · wk-form4_1765972850.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,346 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.95 to $5.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 11:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 1,400 | $4.89 | $6,846.00 |
DisclosureSEC source: 0001628280-25-042524 · wk-form4_1758711627.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,965 Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 10:14 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 1,682 | $4.14 | $6,963.48 |
DisclosureSEC source: 0001628280-25-033200 · wk-form4_1751019274.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,565 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.14 to $4.15. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081724 · ownership.xml · derivative · entry 3 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F4 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 27, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081724 · ownership.xml · derivative · entry 2 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 27, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 9,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-081724 · ownership.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on May 27, 2025. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 11:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 1,839 | $4.75 | $8,735.25 |
DisclosureSEC source: 0000950170-25-046332 · ownership.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,057 Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 11:10 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 3,016 | $4.55 | $13,722.80 |
DisclosureSEC source: 0000950170-24-140921 · ownership.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,218 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.54 to $4.55. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069942 · ownership.xml · derivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054576 · ownership.xml · derivative · entry 2 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024 F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024 Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054576 · ownership.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027924 · doc4.xml · derivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 12:12 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 376,683 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001209191-22-032729 · doc4.xml · derivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,683 Underlying: Common Stock · 376,683 shares Expires 2032-05-25 F1 · derivative.exercise_date: The option vests in 36 substantially equal monthly installments following May 26, 2022, such that the option shall be fully vested on May 26, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 23:15 UTC | TAPESTRY, INC. TPR · Entity 2309 | Tax withholdingCommon Stock | 780 | $51.41 | $40,099.80 |
DisclosureSEC source: 0001225208-18-012779 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,155 F1 · security: These shares were withheld to pay for the taxes in connection with the vesting of the restricted stock units on the Transaction Date. Read SEC document |
| August 13, 2018 Filed Aug 14, 2018 23:27 UTC | TAPESTRY, INC. TPR · Entity 2309 | Tax withholdingCommon Stock | 5,145 | $47.46 | $244,181.70 |
DisclosureSEC source: 0001225208-18-012578 · doc4.xml · nonDerivative · entry 3 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,935 F3 · security: These shares were withheld to pay the taxes in connection with the vesting of restricted stock units. Read SEC document |
| August 13, 2018 Filed Aug 14, 2018 23:27 UTC | TAPESTRY, INC. TPR · Entity 2309 | Tax withholdingCommon Stock | 959 | $47.46 | $45,514.14 |
DisclosureSEC source: 0001225208-18-012578 · doc4.xml · nonDerivative · entry 2 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,080 F2 · security: These shares were withheld to pay for the taxes in connection with the conversion of derivative securities described above. Read SEC document |
| August 13, 2018 Filed Aug 14, 2018 23:27 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 2,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-012578 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,039 F1 · security: Vesting of Performance Restricted Stock Units. Read SEC document |
| August 11, 2018 Filed Aug 13, 2018 22:46 UTC | TAPESTRY, INC. TPR · Entity 2309 | Tax withholdingCommon Stock | 2,624 | $47.93 | $125,768.32 |
DisclosureSEC source: 0001225208-18-012514 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,216 F1 · security: These securities were withheld to pay for the taxes in connection with the vesting of restricted stock units on August 11, 2018. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 21:09 UTC | TAPESTRY, INC. TPR · Entity 2309 | Disposition to issuerCommon Stock | 3,979 | $52.59 | $209,255.61 |
DisclosureSEC source: 0001225208-18-006047 · doc4.xml · nonDerivative · entry 2 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,426 Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 20:30 UTC | TAPESTRY, INC. COH · Entity 2309 | SaleCommon Stock | 8,250 | $41.28 | $340,560.00 |
DisclosureSEC source: 0001225208-17-015002 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,884 Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 22:03 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantCommon Stock | 6,179 | $41.00 | $253,339.00 |
DisclosureSEC source: 0001225208-17-014179 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,134 F1 · security: These securities were acquired in the form of unvested restricted stock units issued under the Amended and Restated Coach, Inc. 2010 Stock Incentive Plan (Amended and Restated as of September 23, 2016) of the Issuer. These securities will vest in four equal tranches on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 17, 2018, the second on August 17, 2019, the third on August 17, 2020 and the fourth on August 17, 2021. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 23:11 UTC | TAPESTRY, INC. COH · Entity 2309 | Tax withholdingCommon Stock | 1,007 | $47.92 | $48,255.44 |
DisclosureSEC source: 0001225208-17-014104 · doc4.xml · nonDerivative · entry 2 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,955 F2 · security: These shares were withheld to pay the taxes in connection with the vesting of restricted stock units. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 23:11 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantCommon Stock | 2,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014104 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,962 F1 · security: Vesting of Performance Restricted Stock Units. Read SEC document |
| August 14, 2017 Filed Mar 13, 2018 21:09 UTC | TAPESTRY, INC. TPR · Entity 2309 | Tax withholdingCommon Stock | 947 | $47.92 | $45,380.24 |
DisclosureSEC source: 0001225208-18-006047 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,015 F1 · security: These shares were withheld to pay for the taxes in connection with the conversion of derivative securities described above. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 23:15 UTC | TAPESTRY, INC. COH · Entity 2309 | Disposition to issuerCommon Stock | 6,913 | $35.72 | $246,932.36 |
DisclosureSEC source: 0001225208-16-041323 · doc4.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · SVP, Controller and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,478 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.